MedTrace Logo

TRU-Cut Biopsy in Tumor cHaracterisation

NCT06816160 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2025-02-10

No results posted yet for this study

Summary

Tru-cut biopsy (TCB) is a minimally invasive method to get an adequate sample from the lesion in order to tailor the appropriate management avoiding unnecessary surgery. The aim of our trial is to evaluate the adequacy, accuracy and safety of the method related to the final histology as reference standard.

Conditions

  • Tumor

Interventions

PROCEDURE

tru-cut biopsy

needle biopsy from the tumor

Sponsors & Collaborators

  • General University Hospital, Prague

    lead OTHER

Principal Investigators

  • David Cibula, prof. · Department of Gynecology, Obstetrics and Neonatology

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-02-01
Primary Completion
2026-01-31
Completion
2027-01-31

Countries

  • Czechia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06816160 on ClinicalTrials.gov